Stifel analyst Nathan Jones reiterated a Buy rating on the shares of Xylem Inc (NYSE:XYL) with a price target of $133.
With the merger of Evoqua Water Technologies Corp, Xylem expects to generate $140 million of cost synergies within three years through savings on duplicative public company costs, procurement, and service footprint, noted the analyst.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased